Xiaomin Wan
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
-
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
- Renal cell carcinoma treatment
Papers in
- Oncology 37
- Cancer Immunotherapy and Biomarkers 18
- Colorectal Cancer Treatments and Studies 11
-
- Gastric Cancer Management and Outcomes 11
- Lung Cancer Treatments and Mutations 11
- Renal cell carcinoma treatment 7
- Co-authors
- Liubao Peng (39 shared papers)Chongqing Tan (53 shared papers)Xiaohui Zeng (41 shared papers)Xia Luo (23 shared papers)Yucong Zhang (3 shared papers)Lidan Yi (25 shared papers)Jianhe Li (14 shared papers)Sini Li (27 shared papers)
- Journals
- Frontiers in Pharmacology (14 papers)Advances in Therapy (10 papers)PLoS ONE (8 papers)Clinical Therapeutics (5 papers)PharmacoEconomics (4 papers)
- Partner nations
- ChinaAustraliaUnited Kingdom
In The Last Decade
Xiaomin Wan
70 papers receiving 1000 citations
Peers
Comparison fields: 5 of 94
- Oncology 553
- Pulmonary and Respiratory Medicine 511
- Economics and Econometrics 247
- Cancer Research 90
- Hepatology 43
Countries citing papers authored by Xiaomin Wan
This map shows the geographic impact of Xiaomin Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomin Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomin Wan more than expected).
Fields of papers citing papers by Xiaomin Wan
This network shows the impact of papers produced by Xiaomin Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomin Wan. The network helps show where Xiaomin Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaomin Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 130 | |
| 2 | 2019 | 89 | |
| 3 | 2013 | 42 | |
| 4 | 2015 | 40 | |
| 5 | 2019 | 40 | |
| 6 | 2012 | 38 | |
| 7 | 2009 | 36 | |
| 8 | 2015 | 35 | |
| 9 | 2019 | 28 | |
| 10 | 2013 | 24 | |
| 11 | 2014 | 23 | |
| 12 | 2020 | 22 | |
| 13 | 2022 | 19 | |
| 14 | 2021 | 19 | |
| 15 | 2021 | 18 | |
| 16 | 2017 | 18 | |
| 17 | 2019 | 17 | |
| 18 | 2018 | 16 | |
| 19 | 2022 | 14 | |
| 20 | 2022 | 13 |
About Xiaomin Wan
Xiaomin Wan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Economics and Econometrics, Surgery and Hematology, having authored 71 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Economic and Financial Impacts of Cancer (17 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers), Gastric Cancer Management and Outcomes (11 papers), Colorectal Cancer Treatments and Studies (11 papers), Lung Cancer Treatments and Mutations (11 papers), Renal cell carcinoma treatment (7 papers) and Biosimilars and Bioanalytical Methods (5 papers). The work is most often cited by research in Oncology (553 citations), Pulmonary and Respiratory Medicine (511 citations), Economics and Econometrics (247 citations), Cancer Research (90 citations) and Hepatology (43 citations). Xiaomin Wan has collaborated with scholars based in China, Australia and United Kingdom. Frequent co-authors include Liubao Peng, Chongqing Tan, Xiaohui Zeng, Xia Luo, Yucong Zhang, Lidan Yi, Jianhe Li, Sini Li, Qiao Liu and Peng Ye. Their work appears in journals such as Frontiers in Pharmacology, Advances in Therapy, PLoS ONE, Clinical Therapeutics and PharmacoEconomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.